(Q36636085)

15 August 2017

1 reference

title

Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease (English)

1 reference

15 August 2017

Raoul Bergner

1

1 reference

15 August 2017

Ingo J Diel

2

1 reference

15 August 2017

Dirk Henrich

3

1 reference

15 August 2017

Martin Hoffmann

4

1 reference

15 August 2017

Michael Uppenkamp

5

1 reference

15 August 2017

language of work or name

1 reference

25 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

29

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

534-540

1 reference

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

15 August 2017

cites work

1 reference

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

21 January 2018

1 reference

Urinary proteins and renal dysfunction in patients with multiple myeloma

21 January 2018

1 reference

Anticancer drug-induced kidney disorders

21 January 2018

1 reference

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

21 January 2018

1 reference

Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

21 January 2018

1 reference

Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity

21 January 2018

1 reference

Renal Failure with the Use of Zoledronic Acid

21 January 2018

1 reference

Safety of long-term administration of bisphosphonates in elderly cancer patients

21 January 2018

1 reference

Comparative tolerability of drug therapies for hypercalcaemia of malignancy

21 January 2018

1 reference

The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats

21 January 2018

1 reference

Serum creatinine is an inadequate screening test for renal failure in elderly patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000096056

1 reference

15 August 2017

1 reference